Biological effects of G1 phase arrest compound, sesquicillin, in human breast cancer cell lines

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Sesquicillin is a compound derived from fungal fermentation.
• Breast cancer proliferation is a significant health concern.
• Understanding cell cycle regulation is crucial for cancer therapy.

Purpose of the Study:

• To investigate the effect of sesquicillin on human breast cancer cell cycle progression.
• To elucidate the molecular mechanisms underlying sesquicillin-induced cell cycle arrest.

Main Methods:

• Human breast cancer cells (MCF-7) were treated with sesquicillin.
• Cell cycle phase distribution was analyzed.
• Expression levels of key cell cycle regulatory proteins (cyclins, CDK inhibitors) were assessed.

Main Results:

• Sesquicillin strongly induced G1 phase arrest in MCF-7 cells.
• This arrest was associated with decreased cyclin D1, cyclin A, and cyclin E expression.
• Protein p21(Waf1/Cip1) (a CDK inhibitor) expression increased in a time-dependent manner.
• The G1 arrest occurred independently of the tumor suppressor protein p53.

Conclusions:

• Sesquicillin inhibits MCF-7 breast cancer cell proliferation via G1 phase arrest.
• The mechanism involves upregulating the CDK inhibitor p21(Waf1/Cip1) and downregulating G1 phase-related cyclins.
• Sesquicillin represents a potential therapeutic agent for breast cancer, acting independently of p53 pathways.